-
Something wrong with this record ?
Development and validation of LC-MS/MS method for quantification of bisphenol A and estrogens in human plasma and seminal fluid
J. Vitku, T. Chlupacova, L. Sosvorova, R. Hampl, M. Hill, J. Heracek, M. Bicikova, L. Starka,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't, Validation Study
Grant support
NT13369
MZ0
CEP Register
- MeSH
- Benzhydryl Compounds analysis blood MeSH
- Chromatography, Liquid methods MeSH
- Endocrine Disruptors analysis blood MeSH
- Estrogens analysis blood MeSH
- Estrone analysis blood MeSH
- Phenols analysis blood MeSH
- Humans MeSH
- Limit of Detection MeSH
- Semen chemistry MeSH
- Tandem Mass Spectrometry methods MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Validation Study MeSH
Bisphenol A (BPA) is a widely known endocrine disruptor with estrogenic, antiestrogenic or antiandrogenic properties. BPA could interfere with estrogen metabolism as well with receptor-mediated estrogen actions. Both environmental BPA and estrogens may be traced in body fluids, of which, besides the blood plasma, the seminal fluid is of particular interest regarding their possible interactions in the testis. The method for simultaneously determining BPA and estrogens is then needed, taking into account that their concentrations in these body fluid may differ. Here the method was developed and validated for measurements of BPA, estrone (E1), estradiol (E2) and estriol (E3) in blood plasma and seminal plasma using liquid chromatography-tandem mass spectrometry. Due to the phenolic moiety of all compounds, dansyl chloride derivatization could be used. The analytical criteria of the method with respect to expected concentration of the analytes were satisfactory. The lower limits of quantifications (LLOQ) amounted to 43.5, 4.0, 12.7, 6.7 pg/mL for plasma BPA, E1, E2 and E3, and 28.9, 4.9, 4.5, 3.4 pg/mL for seminal BPA, E1, E2 and E3, respectively. The concentrations of individual steroids differed between body fluids. To the best of our knowledge, this is the first method that enabled the measurement of estrogens and BPA together in one run. The concentrations of E1, E2 and for the first time also of E3 in seminal plasma in normospermic men are reported.
Charles University Prague Department of Urology Šrobárova 50 100 34 Prague Czech Republic
Faculty Hospital Kralovske Vinohrady Department of Urology Šrobárova 50 100 34 Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16010125
- 003
- CZ-PrNML
- 005
- 20190827140101.0
- 007
- ta
- 008
- 160408s2015 ne f 000 0|engg|
- 009
- AR
- 024 7_
- $a 10.1016/j.talanta.2015.03.013 $2 doi
- 024 7_
- $a 10.1016/j.talanta.2015.03.013 $2 doi
- 035 __
- $a (PubMed)26048824
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Vítků, Jana $u Institute of Endocrinology, Department of Steroids and Proteofactors, Narodni 8, 116 94 Prague, Czech Republic. Electronic address: jvitku@endo.cz. $7 xx0211876
- 245 10
- $a Development and validation of LC-MS/MS method for quantification of bisphenol A and estrogens in human plasma and seminal fluid / $c J. Vitku, T. Chlupacova, L. Sosvorova, R. Hampl, M. Hill, J. Heracek, M. Bicikova, L. Starka,
- 520 9_
- $a Bisphenol A (BPA) is a widely known endocrine disruptor with estrogenic, antiestrogenic or antiandrogenic properties. BPA could interfere with estrogen metabolism as well with receptor-mediated estrogen actions. Both environmental BPA and estrogens may be traced in body fluids, of which, besides the blood plasma, the seminal fluid is of particular interest regarding their possible interactions in the testis. The method for simultaneously determining BPA and estrogens is then needed, taking into account that their concentrations in these body fluid may differ. Here the method was developed and validated for measurements of BPA, estrone (E1), estradiol (E2) and estriol (E3) in blood plasma and seminal plasma using liquid chromatography-tandem mass spectrometry. Due to the phenolic moiety of all compounds, dansyl chloride derivatization could be used. The analytical criteria of the method with respect to expected concentration of the analytes were satisfactory. The lower limits of quantifications (LLOQ) amounted to 43.5, 4.0, 12.7, 6.7 pg/mL for plasma BPA, E1, E2 and E3, and 28.9, 4.9, 4.5, 3.4 pg/mL for seminal BPA, E1, E2 and E3, respectively. The concentrations of individual steroids differed between body fluids. To the best of our knowledge, this is the first method that enabled the measurement of estrogens and BPA together in one run. The concentrations of E1, E2 and for the first time also of E3 in seminal plasma in normospermic men are reported.
- 650 _2
- $a benzhydrylové sloučeniny $x analýza $x krev $7 D001559
- 650 _2
- $a chromatografie kapalinová $x metody $7 D002853
- 650 _2
- $a endokrinní disruptory $x analýza $x krev $7 D052244
- 650 _2
- $a estrogeny $x analýza $x krev $7 D004967
- 650 _2
- $a estron $x analýza $x krev $7 D004970
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a limita detekce $7 D057230
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a fenoly $x analýza $x krev $7 D010636
- 650 _2
- $a sperma $x chemie $7 D012661
- 650 _2
- $a tandemová hmotnostní spektrometrie $x metody $7 D053719
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a validační studie $7 D023361
- 700 1_
- $a Chlupáčová, Tereza $u Institute of Endocrinology, Department of Steroids and Proteofactors, Narodni 8, 116 94 Prague, Czech Republic. Electronic address: tchlupacova@endo.cz. $7 xx0239740
- 700 1_
- $a Kolátorová Sosvorová, Lucie $u Institute of Endocrinology, Department of Steroids and Proteofactors, Narodni 8, 116 94 Prague, Czech Republic. Electronic address: lsosvorova@endo.cz. $7 xx0140729
- 700 1_
- $a Hampl, Richard, $u Institute of Endocrinology, Department of Steroids and Proteofactors, Narodni 8, 116 94 Prague, Czech Republic. Electronic address: rhampl@endo.cz. $d 1941- $7 jo20000074077
- 700 1_
- $a Hill, Martin, $u Institute of Endocrinology, Department of Steroids and Proteofactors, Narodni 8, 116 94 Prague, Czech Republic. Electronic address: mhill@endo.cz. $d 1962- $7 mzk2005304431
- 700 1_
- $a Heráček, Jiří, $u Charles University in Prague, Department of Urology, Šrobárova 50, 100 34 Prague, Czech Republic; Faculty Hospital Kralovske Vinohrady, Department of Urology, Šrobárova 50, 100 34 Prague, Czech Republic; Military University Hospital Prague, Department of Urology, U Vojenske nemocnice 1200, 169 02 Prague, Czech Republic. Electronic address: jiri.heracek@lf1.cuni.cz. $d 1969- $7 nlk20050170272
- 700 1_
- $a Bičíková, Marie $u Institute of Endocrinology, Department of Steroids and Proteofactors, Narodni 8, 116 94 Prague, Czech Republic. Electronic address: mbicikova@endo.cz. $7 xx0060369
- 700 1_
- $a Stárka, Luboslav, $u Institute of Endocrinology, Department of Steroids and Proteofactors, Narodni 8, 116 94 Prague, Czech Republic. Electronic address: lstarka@endo.cz. $d 1930- $7 jn19990209795
- 773 0_
- $w MED00004484 $t Talanta $x 1873-3573 $g Roč. 140, č. - (2015), s. 62-67
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26048824 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20190827140322 $b ABA008
- 999 __
- $a ok $b bmc $g 1113554 $s 934493
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 140 $c - $d 62-67 $e 20150312 $i 1873-3573 $m Talanta $n Talanta $x MED00004484
- GRA __
- $a NT13369 $p MZ0
- LZP __
- $a Pubmed-20160408